EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Higher Lipopolysaccharide Levels Are Linked to Less Anhedonia and Lower Severity of Major Depressive Disorder

Egle Milasauskiene iD, Julius Burkauskas iD, Simonas Jesmanas, Rymante Gleizniene, Vilmante Borutaite, Nijole Raskauskiene, Kristina Skemiene, Virginija Adomaitiene, Brigita Gradauskiene iD, Guy C Brown iD, Vesta Steibliene

Brain Sciences · 12.08.2026 · 16 (8) · 852

DOI: 10.3390/brainsci16080852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Sciences, online erschienen am 12.08.2026. Verfasst von Egle Milasauskiene und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Behavioral Medicine, Neuroscience Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Lithuania, Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory mechanisms contribute to major depressive disorder (MDD) in a subset of patients. Lipopolysaccharide (LPS), a potent inflammatory endotoxin, can induce depressive-like symptoms, but its relationship with specific depressive symptom profiles remains unclear.

Methods

In total, 95 adults with MDD (mean age was 44 ± 14 years) were recruited from psychiatric inpatient and outpatient services. Depressive symptom severity was assessed using the Montgomery–Åsberg Depression Rating Scale (MADRS). Serum concentrations of LPS, IL-10, TNF-α, IL-6, and IFN-γ were measured by ELISA. Associations between inflammatory markers and depressive symptoms were examined using group comparisons, correlation analyses, multivariable linear regression, quantile regression, and mediation analyses adjusted for demographic and clinical covariates.

Results

Patients with severe depression exhibited significantly lower circulating LPS levels than those with mild-to-moderate depression (95.6 vs. 165.2 pg/mL, p = 0.007), despite no significant differences in cytokine concentrations. LPS levels were inversely associated with depression severity, anhedonia factor score, and MADRS item 8 (“inability to feel”). Lower LPS concentrations were independently predicted by higher inability to feel, reduced appetite and combined pharmacotherapy use. Quantile regression demonstrated heterogeneity across the LPS distribution, with symptom–LPS associations evident among patients with higher LPS concentrations. Higher LPS levels were associated with greater apparent sadness, concentration difficulties, and reduced sleep, but lower levels of anhedonia, less reduced appetite, less lassitude, lower inner tension, and lower suicidality. Mediation analyses indicated that anhedonia mediated the association between LPS levels and depression severity.

Conclusions

Higher circulating LPS may characterize a biologically distinct subgroup of MDD patients with lower symptom severity and less anhedonia, supporting biological heterogeneity within MDD.

Schlagwörter

Stichwörter der Autor:innen

anhedoniaendotoxinsimmune dysregulationlipopolysaccharidesmajor depressive disorder

Autor:innen und Institutionen

  • Laboratory of Behavioral Medicine, Neuroscience Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
  • Department of Psychiatry, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
  • Department of Radiology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
  • Laboratory of Biochemistry, Neuroscience Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
  • Department of Immunology and Allergology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
  • Department of Biochemistry, University of Cambridge, Cambridge CB21QW, UK.

ORCID-Profile: Egle Milasauskiene, Julius Burkauskas, Brigita Gradauskiene, Guy C Brown

Förderung

  • Research Council of Lithuania
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Milasauskiene, E., Burkauskas, J., Jesmanas, S., Gleizniene, R., Borutaite, V., Raskauskiene, N., Skemiene, K., Adomaitiene, V., Gradauskiene, B., Brown, G. C., & Steibliene, V. (2026). Higher Lipopolysaccharide Levels Are Linked to Less Anhedonia and Lower Severity of Major Depressive Disorder. Brain Sciences, 16(8), 852. https://doi.org/10.3390/brainsci16080852

Vancouver

Milasauskiene E, Burkauskas J, Jesmanas S, Gleizniene R, Borutaite V, Raskauskiene N, et al. Higher Lipopolysaccharide Levels Are Linked to Less Anhedonia and Lower Severity of Major Depressive Disorder. Brain Sciences. 2026;16(8):852. doi:10.3390/brainsci16080852

BibTeX
@article{Milasauskiene2026,
  author = {Milasauskiene, Egle and Burkauskas, Julius and Jesmanas, Simonas and Gleizniene, Rymante and Borutaite, Vilmante and Raskauskiene, Nijole and Skemiene, Kristina and Adomaitiene, Virginija and Gradauskiene, Brigita and Brown, Guy C and Steibliene, Vesta},
  title = {Higher Lipopolysaccharide Levels Are Linked to Less Anhedonia and Lower Severity of Major Depressive Disorder},
  journal = {Brain Sciences},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {852},
  doi = {10.3390/brainsci16080852}
}
Kostenlos starten →